Home/ Stocks/ CNSP

CNS Pharmaceuticals, Inc. Common Stock

CNSP XNAS

$7.29 +0.30 (+4.23%) ▲ 15-min delayed

Open

$7.04

High

$7.64

Low

$7.02

Volume

212.5K

Market Cap

$5.92M

About CNS Pharmaceuticals, Inc. Common Stock

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 8 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-15,850,564	$-35.75
FY 2025	$0	$-15,850,564	$-35.75
Q3 2025	$0	$-3,218,481	$-5.76
Q2 2025	$0	$-2,374,961	$-6.42

TickerDaily Coverage

Stock Market Today, May 8, 2026: Weekly Recap of Explosive Movers Led by CNSP's 326% Surge

Market News David Brooks · 14h ago

Friday, May 8, 2026 closes out a volatile week dominated by explosive moves in micro-cap and...

Why Is CNS Pharmaceuticals, Inc. Common Stock (CNSP) Stock Up 326.6% Today?

Market News Alex Chen · 4d ago

CNS Pharmaceuticals (CNSP) stock exploded higher Monday, gaining 326.6% to $9.50 per share on...

View All Coverage →

Get CNSP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CNS Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.